Factors determining insulin resistance in chronic hemodialysis patients

Contributions to Nephrology

Volumn 171, Issue , 2011, Pages 127-134

  Hung, Adriana M ^a,b   Ikizler, T Alp ^a,b,c  

^a Veterans Administration   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; GLUCOSE;

ARTICLE; BLOOD; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; METABOLISM; RENAL REPLACEMENT THERAPY; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY;

ADIPOKINES; CHRONIC DISEASE; GLUCOSE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; VITAMIN D DEFICIENCY;

EID: 79958105989     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000327177     Document Type: Article

References (49)

1. Collins AJ, Foley RN, Herzog C, et al: US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 2011;57:A8, e1-e526.
2. Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T: Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 2005;45: 275-280. (Pubitemid 40431052)
3. DeFronzo RA, Tobin JD, Rowe JW, Andres R: Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 1978;62:425-435. (Pubitemid 8393313)
4. Hanley AJ, Williams K, Stern MP, Haffner SM: Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 2002;25: 1177-1184. (Pubitemid 41071169)
5. Wen CP, Cheng TY, Tsai SP, Hsu HL, Wang SL: Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan. Diabetes Care 2005; 28:2756-2761. (Pubitemid 43958385)
6. Becker B, Kronenberg F, Kielstein JT, et al: Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 2005;16:1091-1098. (Pubitemid 41710320)
7. Shinohara K, Shoji T, Emoto M, et al: Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002;13: 1894-1900. (Pubitemid 34700615)
8. Hung AM, Ikizler TA: A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patients. Clin J Am Soc Nephrol 2011, in press.
9. Matsuhisa M, Yamasaki Y, Emoto M, et al: A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects. Diabetes Res Clin Pract 2007;77:151-154. (Pubitemid 46590462)
10. Kotani K, Sakane N, Saiga K, Kurozawa Y: Leptin:adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intima-media thickness. Diabetologia 2005;48: 2684-2686. (Pubitemid 41738239)
11. Satoh N, Naruse M, Usui T, et al: Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 2004;27:2488-2490. (Pubitemid 39281406)
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
13. Katz A, Nambi SS, Mather K, et al: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410. (Pubitemid 32269192)
14. McAuley KA, Williams SM, Mann JI, et al: Diagnosing insulin resistance in the general population. Diabetes Care 2001;24:460-464. (Pubitemid 32198413)
15. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J: Insulin resistance in uremia. J Clin Invest 1981;67:563-568. (Pubitemid 11141740)
16. Adrogue HJ: Glucose homeostasis and the kidney. Kidney Int 1992;42: 1266-1282.
17. Siew ED, Ikizler TA: Determinants of insulin resistance and its effects on protein metabolism in patients with advanced chronic kidney disease. Contrib Nephrol 2008;161:138-144.
18. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM: Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994;91:4854-4858. (Pubitemid 24177748)
19. Shoelson SE, Lee J, Goldfine AB: Inflammation and insulin resistance. J Clin Invest 2006;116:1793-1801. (Pubitemid 44033299)
20. Larsen CM, Faulenbach M, Vaag A, et al: Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356:1517-1526. (Pubitemid 46588416)
21. Hung AM, Ellis CD, Shintani A, Booker C, Ikizler TA: IL-1 beta inhibition improves chronic inflammation in hemodialysis patients. J Am Soc Nephrol 2011;22:437-442.
22. Hung A, Pupim L, Yu C, et al: Determinants of C-reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilization. Hemodial Int 2008;12:236-243. (Pubitemid 351494279)
23. Stenvinkel P, Wanner C, Metzger T, et al: Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int 2002;62:1791-1798. (Pubitemid 35286288)
24. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469-476. (Pubitemid 30124077)
25. Trirogoff ML, Shintani A, Himmelfarb J, Ikizler TA: Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3-4 chronic kidney disease patients. Am J Clin Nutr 2007; 86:1642-1648. (Pubitemid 350232178)
26. Wajchenberg BL: Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697-738. (Pubitemid 32113289)
27. Scherer PE: Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006;55:1537-1545. (Pubitemid 44324105)
28. Fox CS, Massaro JM, Hoffmann U, et al: Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48. (Pubitemid 47016245)
29. Axelsson J, Rashid Qureshi A, Suliman ME, et al: Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004;80:1222-1229. (Pubitemid 41350682)
30. Iwabu M, Yamauchi T, Okada-Iwabu M, et al: Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 2010;464:1313-1319.
31. Drechsler C, Krane V, Winkler K, Dekker FW, Wanner C: Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients. Kidney Int 2009;76:567-575.
32. Menon V, Li L, Wang X, et al: Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006;17:2599-2606. (Pubitemid 44300977)
33. Cohen B, Novick D, Rubinstein M: Modulation of insulin activities by leptin. Science 1996;274:1185-1188. (Pubitemid 26389283)
34. Loffreda S, Yang SQ, Lin HZ, et al: Leptin regulates proinflammatory immune responses. FASEB J 1998;12: 57-65. (Pubitemid 28060271)
35. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, Brownlee M: Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001;276: 25096-25100.
36. Wolf G, Hamann A, Han DC, et al: Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis (see comments 1999;56:1154-1155). Kidney Int 1999;56:860-872. (Pubitemid 29411714)
37. Teta D, Maillard M, Halabi G, Burnier M: The leptin/adiponectin ratio: potential implications for peritoneal dialysis. Kidney Int Suppl 2008: S112-S118. (Pubitemid 351466527)
38. Kotani K, Shimohiro H, Sakane N: The relationship between leptin:adiponectin ratio and carotid intima-media thickness in asymptomatic females. Stroke 2008;39: e32-e33, author reply e4. (Pubitemid 351619499)
39. Takamura N, Hayashida N, Hagane K, et al: Leptin to high-molecular-weight adiponectin ratio is independently correlated with carotid intima-media thickness in men, but not in women. Biomarkers 2010;15:340-344.
40. Mak RH: Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 1992;41:1049-1054.
41. Gunal AI, Celiker H, Celebi H, Ustundag B, Gunal SY: Intravenous alfacalcidol improves insulin resistance in hemodialysis patients. Clin Nephrol 1997;48:109-113. (Pubitemid 27371040)
42. Kautzky-Willer A, Pacini G, Barnas U, et al: Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 1995;47:200-206.
43. Kopple JD, Kalantar-Zadeh K, Mehrotra R: Risks of chronic metabolic acidosis in patients with chronic kidney disease. Kidney Int Suppl 2005:S21-S27. (Pubitemid 43361552)
44. Roderick P, Willis NS, Blakeley S, Jones C, Tomson C: Correction of chronic metabolic acidosis for chronic kidney disease patients. Cochrane Database Syst Rev 2007:CD001890.
45. Wang X, Hu Z, Hu J, Du J, Mitch WE: Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 2006;147:4160-4168. (Pubitemid 44268367)
46. Mak RH: Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int 1998;54:603-607. (Pubitemid 28357424)
47. Reaich D, Graham KA, Channon SM, et al: Insulin-mediated changes in PD and glucose uptake after correction of acidosis in humans with CRF. Am J Physiol 1995;268:E121-E126.
48. Abe M, Okada K, Maruyama T, Maruyama N, Soma M, Matsumoto K: Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis. Expert Opin Pharmacother 2010;11: 1611-1620.
49. Goldberg AP, Geltman EM, Gavin JR 3rd, et al: Exercise training reduces coronary risk and effectively rehabilitates hemodialysis patients. Nephron 1986;42:311-316. (Pubitemid 16156304)